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Background: It is sometimes diﬃcult to diﬀerentiate the transient appearance of atrial
ﬁbrillation (AF) after pulmonary vein (PV) isolation from a true recurrence of AF. We
attempted to diﬀerentiate them by analyzing the time course after the procedure.
Methods and Results: 79 patients who underwent PV isolation were divided into two
groups (successful: N ¼ 60 and unsuccessful: N ¼ 19) according to the ﬁnal outcome.
Antiarrhythmic drugs were used either temporarily or continuously to treat re-appearance of
AF after the procedure. The transient appearance of AF in the successful group gradually
faded, while true AF recurrence in the unsuccessful group consistently increased in line with
the follow-up (F/U) period. The appearance of AF after 3 months predicted a subsequent
failure of the procedure with a positive/negative predictive value of 87/90%, respectively.
Conclusion: Since the transient appearance of AF decreased and the true recurrence of AF
increased in line with the F/U period, we should therefore wait at least 3 months before
judging the outcome of PV isolation.
(J Arrhythmia 2006; 22: 98–102)
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Introduction
Pulmonary vein (PV) isolation has been shown to
be an eﬀective treatment for patients with parox-
ysmal and persistent atrial ﬁbrillation (AF).1–4)
However, a recurrence of AF following ablation is
one of the major limitations of this procedure.5,6)
Although the appearance of AF early after PV
isolation is well known to often occur as a transient
phenomenon and thereafter it fades out naturally,7,8)
there are sometimes patients who require early
repeat procedures due to severe symptoms caused
by AF recurrence. Therefore it is useful to know the
best timing to judge the outcome of the PV isolation
procedure in order to minimize any unnecessary
repeat procedures.
Methods
Study subjects
This study consisted of 79 consecutive patients
with AF (paroxysmal: 51, persistent: 28, mean age:
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51:5 9:9 years) who underwent PV isolation
targeting all four PVs. All patients were subsequent-
ly observed for more than 12 months (mean
observation period: 27:5 7:6 months).
Electrophysiological study
After each of the patients gave their written
informed consent, an electrophysiological study was
performed as described previously.9) A 7F 8-mm-tip
quadripolar ablation catheter (7F BlazerII, Boston
Scientiﬁc) and a decapolar circular mapping catheter
(Lasso, Biosense Webster) were placed transseptally
at the ostium or antrum of targeted PVs. Selective
PV angiography was performed by the hand injec-
tion of contrast medium (10–20ml) in biplane views
and then was displayed during the procedure to show
the venous anatomy and the location of the left
atrium (LA)-PV junction. PV mapping was per-
formed with a steerable circular Lasso catheter with
a diameter of either 15, 20, 25 or 30mm. The PV
potentials (PVPs) were deﬁned as described previ-
ously and recorded in a bipolar mode of 10 bipoles
(1 to 2, 3 to 4, . . ., up to 19 to 20) through band-pass
ﬁlters of 30 to 500Hz and an ampliﬁcation of 1 to
2 cm/mV on polygraphy (EP Med System, Inc).
Ablation procedure
In each case, all four PVs were targeted to be
electrically disconnected from the LA. Radiofre-
quency (RF) current ablation was performed as
proximally as possible at its ostium or antrum during
either sinus rhythm or AF. The segment of the PV
ostial perimeter identical to the earliest activation
site with the electrogram polarity reversal9) was
preferentially targeted. RF energy was applied at a
target temperature of 50 C with a power limit of 30
to 35W for 60 to 90 seconds at each site. The end
point was the establishment of the bidirectional
block between the LA and PV.10) After the elimi-
nation of all PVPs, an absence of conduction from
PV to LA was also conﬁrmed by pacing inside the
PV with the Lasso catheter. If the patients had atrial
ﬂutter, then cavotricuspid isthmus ablation was also
performed. No linear ablation was performed in-
cluding the posterior left atrium and mitral isthmus.
After the complete PV isolation was conﬁrmed,
provocative maneuvers (isoproterenol infusion or
burst pacing) were performed to reveal other foci
and additional RF ablation was performed if neces-
sary.
Clinical outcome and patient follow-up
In this study, we waited at least 6 months before
the outcome of the procedure was judged. An
‘‘unsuccessful’’ procedure was deﬁned as the re-
appearance of AF which was sustained more than 1
minute, while a ‘‘successful’’ procedure was deﬁned
as the disappearance of AF during the 6 months of
observation period. When frequent AF episodes
appeared within 6 months after the procedure,
antiarrhythmic drugs (AADs) were administered
either temporarily or continuously. Generally, AADs
were gradually tapered and discontinued during the
course of observation period, however, they were
maintained in some cases on the basis of patients’
wishes even if stable sinus rhythm was kept during
F/U period. All patients were given a periodical
follow-up (once a month) in an outpatient clinic and
a recurrence of AF was evaluated based on the
symptoms, ECG recordings and 24-hour ambulatory
monitorings (1, 3, 6, 9, and 12 months after the
procedure). Repeat PV isolation procedures were
recommended for patients who were judged to be
‘‘unsuccessful’’ after being treated with this proce-
dure.
Statistical analysis
All values are expressed as mean SD. A
statistical analysis was performed using Student’s
t-test (unpaired) or chi-square analysis. Diﬀerences
with p < 0:05 were considered to be statistically
signiﬁcant.
Results
Patient characteristics and procedure outcome
In total, 98% (311/316) of the targeted PVs were
electrically isolated from LA during the session.
Table 1 Comparison of characteristics of successful and
unsuccessful group.
Successful
Group
(n ¼ 60)
Unsuccessful
Group
(n ¼ 19)
P value
Age (yrs) 51:9 9:9 51:3 10:0 NS
Men/women 51/9 18/1 <0:0001
Paroxysmal AF/
persistent AF 43/17 8/11 0.028
Duration of AF
(yrs) 4:2 4:1 5:6 5:3 NS
EF (%) 65:7 5:3 64:4 11:6 NS
Left atrial
diameter (mm) 36:9 5:2 37:6 4:6 NS
Organic heart
disease (þ=) 17/43 7/12 NS
Antiarrhythmic
drugs 3:5 1:4 3:3 1:3 NS
AF indicates atrial ﬁbrillaiton; EF, ejection fraction.
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After 27:5 7:6 months of follow-up, 19 (24%)
patients were classiﬁed as belonging to the ‘‘un-
successful’’ group while the remaining 60 (76%)
patients were classiﬁed as belonging to the ‘‘suc-
cessful’’ group for this procedure. The clinical
characteristics of both groups are given in Table 1.
The greater number of patients with persistent AF
and a male gender were included in the ‘‘unsuccess-
ful’’ group in comparison to the ‘‘successful’’ group
(p < 0:05 and p < 0:001, respectively).
In the ‘‘unsuccessful’’ group (N ¼ 19), AF ap-
peared in 32% (6/19), 53% (10/19), 53% (10/19),
63% (12/19), 63% (12/19), and 63% (12/19) of
patients at 1 week, 1, 2, 3, 4, and 5 month after
PV isolation procedure, respectively. As shown in
Figure 1, the frequency of AF increased in the
‘‘unsuccessful’’ group in line with the time after
the procedure. On the other hand, in the ‘‘successful’’
group (N ¼ 60), the frequency of AF decreased in
line with the duration of the F/U period (30% (18/
60), 22% (13/60), 13% (8/60), 5% (3/60), 5% (3/
60), and 3% (2/60) at 1 week, 1, 2, 3, 4, and 5
months after the PV isolation procedure respective-
ly). In total, the appearance of AF at 1 week, 1, 2, 3,
4 and 5 months predicted the ﬁnal success or failure
of this procedure with a positive/negative predictive
value of 25/76%, 41/82%, 56/85%, 80/89%, 80/
89% and 86/89%, respectively (Table 2). The ap-
pearance of AF later than 3 months, but not within 3
months after the PV isolation, correlated well with a
poor long-term outcome (p < 0:01). In the ‘‘suc-
cessful’’ group, 13% (8/60) of patients temporarily
and 10% (6/60) of patients continuously needed to
take previously ineﬀective AADs to prevent AF
recurrence (6: bepridil, 4: pilsicanide, 2: cibenzoline,
1: disopyramide, 1: ﬂecainide). On the other hand, in
the ‘‘unsuccessful’’ group, all 19 patients experi-
enced AF recurrence even under AADs (8: bepridil,
6: pilsicanide, 2: cibenzoline, 1: disopyramide, 1:
ﬂecainide, 1: pirmenol).
Among the 19 patients classiﬁed as ‘‘unsuccess-
ful’’, 17 patients underwent repeat PV isolation
procedures (2 patients refused). Re-conduction of
previously isolated PVs were seen in 3:3 0:5 PVs
in all 17 patients. 16/17 (94%) patients were free
from AF after repeat ablation. In addition, 2 patients
underwent an ablation of non-PV foci in addition to
PV isolation.
Complications
Cardiac tamponade occurred in one patient during
the procedure, which was relieved by percutaneous
drainage. In addition, an asymptomatic left inferior
PV stenosis (50–75%) was observed a long time
after the procedure in one patient.
Discussion
This study shows that there are two types of AF
recurrence after the PV isolation procedure. One is a
transient re-appearance of AF while the other type is
a true recurrence of AF requiring repeat PV isolation
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Figure 1 The relationship between the time course and AF appearance.
The white and gray bars represent AF recurrence at each month in the successful and unsuccessful group,
respectively. 1W and 1–6M indicate 1 week and 1–6 months after ablation, respectively.
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procedures. Although it is quite diﬃcult to discrim-
inate these two types of AF recurrence from the ECG
ﬁndings, the time course of their appearance or
disappearance may be useful for their diﬀerentiation.
We found that the former type of AF recurrence
appears at a relatively early phase during the
observation period and then subsides naturally,
whereas the latter increases in line with the obser-
vation period. Since the positive and negative
predictive value of the AF appearance for the failure
of the procedure reached up to 80% and 89% at 3
month F/U, respectively, we determined that we
should wait at least 3 months before making a ﬁnal
judgment to perform repeat procedures in order to
avoid unnecessary ablation procedures.
Although there may be multiple causes for
transient appearance of AF after PV isolation, it
has been shown to be mainly related to the acute
inﬂammatory change in the tissue resulting from the
application of RF energy.7,8) Previous reports dem-
onstrated that RF application induces the local
proliferation of inﬂammatory cells (subclinical peri-
carditis), and it takes several weeks for the dis-
appearance of these inﬂammatory changes.11,12) The
gradual disappearance of transient AF recurrence
over several weeks in this patient population was
closely compatible with the histopathogenic changes
documented above.
There have been several reports regarding the
causes of true AF recurrence after the PV isolation
procedure. The main cause of AF recurrence has
been shown to be the recovery of PV-LA conduc-
tion.13–16) Callans et al.15) reported that a recovery of
PV-LA conduction was observed in 97% of patients,
and 86% of them were free of AF after repeat PV
isolation procedures. Ouyang et al.16) also reported
recovered PV-LA conduction to be observed in 81%
of patients at the repeat procedure, and 95.5% of
them were free from AF after repeat PV isolation
procedure. In this study, a recovered PV-LA con-
duction was observed in 3:3 0:5 PVs in all 17
patients who underwent repeat procedures for the
recurrence of AF. In addition, 94% of them
subsequently became free from AF after the repeat
sessions. These results suggest a recovery of PV-LA
conduction to be the main and exclusive cause of
true AF recurrence after the PV isolation procedure
and vigorous attempts of repeat PV isolation is
recommended for the complete cure of AF.
In this study, re-conduction of previously isolated
PVs were observed in all patients (mean 3.3 PVs)
who underwent repeat PV isolation. Since repeat
procedure was not performed in the successful
group, presence/absence of PV re-conduction in
cases without AF-recurrence was not known. As
shown above, 10% of patients in the successful
group continuously took AADs during the whole
observation period. Those ﬁndings might suggest
that patients in the successful group were more
sensitive to AADs compared to those in the
unsuccessful group, and re-conducted PVs were
pharmacologically re-isolated, as shown by Kumagai
et al.17)
There have been a few studies describing rela-
tively poor long-term outcome in cases with early
AF appearance after PV isolation. Oral et al.7)
reported that about 30% of patients with early AF
appearance (within 2 weeks after the procedure)
were free from AF without AADs during a mean
F/U period of 7 months. O’Donnell et al.18) also
reported that 39% of patients with early AF
appearance (within 3 months) were free from AF
under AADs during a mean observation period of
9 months. In this study we showed a much higher
long-term successful rate (67%) with or without
AADs. Although the reason of these discrepancies
among studies is not known, they might be caused by
diﬀerent PV isolation protocols. Isolation of all four
PVs was achieved in only 28% of patients in the
study of Oral et al. and also only 2.5 PVs (mean) per
patient were isolated in the O’Donnell study. In our
study, all four PVs were successfully electrically
isolated in 98% of cases, which would be related to
the better long-term outcome of our patients with
early AF re-appearance after PV isolation.
Limitations
There are several limitations in this study. First,
Table 2 Predictive accuracies of AF recurrence for the ﬁnal outcome.
1 W 1 M 2 M 3 M 4 M 5 M 6 M
Sensitivity 32% 47% 53% 63% 63% 63% 63%
Speciﬁcity 70% 78% 87% 95% 97% 97% 97%
PPV 25% 41% 56% 80% 80% 86% 86%
NPV 76% 82% 85% 89% 89% 89% 89%
PPV indicates positive predictive value; NPV, negative predictive value; 1W, 1 week after ablation; 1–6M,
1–6 months after ablation.
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because the clinical outcome of the PV isolation
procedure was judged based on the patients’ symp-
toms, serial ECGs, and 24-hour ambulatory mon-
itoring, patients with asymptomatic AF recurrences
could thus have been underestimated. Second, a
relatively small number of patients were evaluated in
this study. Studies with a larger number of patients
should therefore be performed for a more detailed
analysis.
Conclusion
A transient AF appearance after the PV isolation
procedure generally fades out during a 3 month
observation period, while the true AF recurrence
increases in line with the time after the procedure.
We should wait at least 3 months before judging the
outcome of PV isolation to avoid any unnecessary
repeat ablation procedures.
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